What's new

Human medicines European public assessment report (EPAR): Ryjunea, Status: Opinion

Human medicines European public assessment report (EPAR): Ryjunea, Status: Opinion

Mar 28, 2025 - 12:00
 0
Human medicines European public assessment report (EPAR): Ryjunea, Status: Opinion
Human medicines European public assessment report (EPAR): Ryjunea, Status: Opinion
Read More

Tags:

Previous Article

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP...

Next Article

Human medicines European public assessment report (EPAR): Kisunla, donanemab, St...

Related Posts

EVVet3 EVWeb Production - Release notes

Mar 31, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, Indacaterol (acetate),Mometasone (furoate) (QVM149),Glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0493/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 24, 2025  0